col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


163 Results       Page 1

 [1] 
American Association for Cancer Research: Cancer Research
  original article Date Title Authors   All Authors
1 [GO] 2024―Mar―22 Abstract 4827: Financial toxicity among cancer survivors during the COVID-19 pandemic Tanvi Srivastava, Salma Shariff-Marco, Samuel L. Washington, Christine Miaskowski, June M. Chan
2 [GO] 2024―Mar―22 Abstract 1295: CancerCare coping circle workshop for patients with cancer and covid-19 Christine Verini, Sarah Paul, Rebecca Ashkenazy, Brittany Wolf Gianares
3 [GO] 2024―Mar―22 Abstract 4797: Impact of COVID-19 pandemic on breast cancer screening and diagnosis stage in a large midwestern United States academic medical center Kimberly J. Johnson, RJ Waken, Caitlin P. O'Connell, Derek Brown
4 [GO] 2024―Mar―22 Abstract 787: SARS-COV-2 P.1 strain infection in lung, breast and colon tumoral patient-derived organoids Tayanne F. Sassaro, Anael Viana, Mariano Zalis, Carlos Gil Moreira Ferreira, Jorge Canedo, Danielle Ferreira, et al. (+9)
5 [GO] 2024―Jan―16 Abstract A013: Uptake and predictors of Covid-19 vaccination among United States’ cancer populations Tayla Greene, Kikelomo Olaosebikan, Osahon Idolor, James Appiah-Pippim
6 [GO] 2023―Jun―09 Abstract 5523: Impact of COVID-19 on longitudinal breast cancer research studies involving TNBC patients Cherie Bates, Esther Kong, Elena Zaikova, Samuel Aparicio, Karen Gelmon
7 [GO] 2023―Apr―14 Abstract LB054: Establishment of an infrastructure for rapid pandemic response at the Frederick National Laboratory Nancy V. Roche, Troy Kemp, Ligia Pinto, Tom Hickey
8 [GO] 2023―Apr―05 Abstract 5590: Liquid biopsy testing in metastatic or advanced breast cancer patients during the COVID-19 pandemic Benjamin L. Furman, Ebru Baran, Sonal Brahmbhatt, Betty Chan, Ka Mun Nip, Adrian Kense, et al. (+5)
9 [GO] 2023―Apr―04 Abstract 794: Repurposing of poly-γ-glutamic acid, immunotherapeutic drug for cervical intraepithelial neoplasia 1, as covid-19 treatment Chan-Hee Yoo, Jae Chul Choi, Do Young Lee, Chun-Soo Lee, Young-Chul Park
10 [GO] 2023―Apr―04 Abstract 795: T-cell mediated response to emerging COVID-19 strains in patients with cancer studied via deep learning Olga Lyudovyk, Yuval Elhanati, Artem Streltsov, Quaid Morris, Santosha Vardhana, Benjamin Greenbaum
11 [GO] 2023―Apr―04 Abstract 799: Measuring the impact of the COVID-19 pandemic on breast cancer screening in Puerto Rico Vivian Colón-López, Hermilis Berrios Ortiz, Hector Contreras-Mora, Orville M. Disdier, Cynthia M. Pérez, Nilda Ríos, et al. (+3)
12 [GO] 2023―Apr―04 Abstract 800: Participation in COVID-19 clinical trials, willingness to participate, and trust in sources of information among persons with and without cancer in Puerto Rico.   Fabiola A. Rivera-Gastón, Hérmilis Berríos-Ortiz, Jeslie M. Ramos-Cartagena, Andrea López-Cepero, Vivian Colón-López, Cynthia M. Pérez, Ana P. Ortiz
13 [GO] 2023―Apr―04 Abstract 801: The impact of COVID-19 on colorectal screening in Puerto Rico Héctor M. Contreras-Mora, Erick L. Suárez-Pérez, Cynthia M. Pérez, Hérmilis Berríos-Ortiz, Orville M. Disdier, Nilda Ríos, et al. (+3)
14 [GO] 2023―Apr―04 Abstract 806: Enhancer deregulation inTET2-mutant clonal hematopoiesis is associated with increased COVID-19 severity and mortality Moritz Binder, Terra L. Lasho, Wazim Mohammed Ismail, Nana A. Ben-Crentsil, Jenna A. Fernandez, Minsuk Kim, et al. (+20)
15 [GO] 2023―Apr―04 Abstract 797: COVID-19 vaccines in patients with solid tumor cancers receiving immune checkpoint inhibitors Danielle Gilbert, Junxiao Hu, Elaine T. Lam
16 [GO] 2023―Apr―04 Abstract 804: The temporal evolution in disease phenotype of COVID-19 hospitalisation, intensive care and case fatality rates in cancer patients across the United Kingdom (UKCCP) Thomas Starkey, Maria C. Ionescu, Matthew W. Fittall, Michael Tilby, Alex Burnett, Rosie Hattersley, et al. (+11)
17 [GO] 2023―Apr―04 Abstract 805: Association of state-level COVID-19 mortality rates with real-world progression and real-world overall survival among patients with advanced non-small cell lung cancer, 2020-2022 Maneet Kaur, Christina M. Parrinello, Jenny S. Guadamuz, Trevor J. Royce, Gregory S. Calip
18 [GO] 2023―Apr―04 Abstract 807: Inflammatory biomarkers: Breast cancer survival and possible role in COVID-19 associated comorbidity Alakesh Bera, Eric Russ, Surya Radhakrishnan, Hai Hu, COL Craig D. Shriver, Meera Srivastava
19 [GO] 2023―Apr―04 Abstract 787: Lung cancer screening use before & during the COVID-19 pandemic in the US: Population-based evidence from 2019-2021 Hermine Poghosyan, Sayantani Sarkar, Ilana Richman
20 [GO] 2023―Apr―04 Abstract 792: SARS-CoV-2 spike S1 mediated lung tumor regression in a mouse model Monica Sheinin, Kalipada Pahan, Ramesh K. Paidi
21 [GO] 2023―Apr―04 Abstract 802: Identifying factors that affect barriers to lymphoma treatment during the COVID - 19 pandemic Cherie D. Bates, Steve E. Kalloger, Lorna E. Warwick
22 [GO] 2023―Mar―02 Abstract P3-03-11: Racial and Ethnic Disparities in Screening Mammography During COVID-19 Arissa Milton, Ryan Woods, Mai Elezaby, Kelly Hackett, Joan Neuner, Anand Narayan, Roberta Strigel
23 [GO] 2023―Mar―02 Abstract P4-03-36: Determinants of severe COVID-19 infection in Patients with Breast Cancer from a Community Oncology Practice in Brazil Fanny Cascelli, Matheus Costa e Silva, Rodrigo Dienstmann, Bruno L. Ferrari, Carlos Gil Ferreira, Max S. Mano, et al. (+4)
24 [GO] 2023―Mar―02 Abstract P1-05-20: COVID-19 Lockdown Resulting in Advanced Cancer and Worse Histology at Presentation in Hispanics Juzar Hussain, Gabriel Roman Souza, Tamarah Aldawoodi, Lauren C. Jameson, Lauren Rahman, Nomso C. Agim, et al. (+2)
25 [GO] 2023―Mar―02 Abstract P6-05-13: The Psychological Impacts of COVID-19 on Breast Cancer Patients in China Yijia Wang, Yuqing Yang, Changjiao Yan, Jixin Yang, Hongliang Wei, Wen Ma, Nanlin Li
26 [GO] 2023―Mar―02 Abstract P4-03-25: Patient-level predictors of skipping screening mammograms during the COVID-19 pandemic at a large tertiary care center in Texas Maryam Nemati Shafaee, Omar Rosales, Randall Parker Kirby, Tamara Ortiz-Perez, Luke Gilman, Ashley Hardeman, et al. (+3)
27 [GO] 2023―Mar―02 Abstract P1-05-22: The Impact of the COVID-19 Pandemic on Breast Cancer Diagnoses in San Antonio, TX Gabriel Roman Souza, Tamarah Aldawoodi, Juzar Hussain, Lauren C. Jameson, Lauren Rahman, Nomso C. Agim, et al. (+2)
28 [GO] 2023―Mar―02 Abstract P4-03-29: Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway Anouk Eijkelboom, Linda de Munck, Marthe Larsen, Jan Nygård, Solveig Hofvind, Sabine Siesling
29 [GO] 2023―Mar―02 Abstract P1-05-19: Impact of the COVID-19 pandemic on the diagnostic pathway of breast cancer in the Netherlands: a population-based study Wouter Wolfkamp, Joyce Meijer, Jolanda Van Hoeve, Jeroen Veltman, Sabine Siesling
30 [GO] 2023―Mar―02 Abstract P1-05-21: Change in breast cancer detection method, stage at diagnosis and treatment during the COVID-19 Pandemic: 2019-2021 Judith A. Malmgren, Mary Atwood, Henry Kaplan
31 [GO] 2023―Mar―02 Abstract P5-03-16: Changes in preferences for ovarian cancer prevention strategies during the COVID-19 pandemic: Results of a discrete choice experiment Brian Egleston, Mary Daly, Kaitlyn Lew, Lisa Bealin, Alexander Husband, Jill Stopfer, et al. (+5)
32 [GO] 2023―Mar―02 Abstract P6-08-07: Reasons for Reduced Willingness to Participate in Clinical Trials During the COVID-19 Pandemic: The Translational Breast Cancer Research Consortium (TBCRC) 057 Survey Karen L. Smith, Carolyn Mead-Harvey, Gina L. Mazza, Albert E. Holler, Eileen Shinn, Elizabeth Frank, et al. (+7)
33 [GO] 2023―Mar―02 Abstract P1-12-04: Side Effects of the mRNA COVID-19 Vaccines in Women Treated for Breast Cancer Brooke Juhel, Cheryl L. Brunelle, Madison C. Bernstein, Louisa H. Smith, Amanda W. Jung, Elizabeth K. Hausman, et al. (+3)
34 [GO] 2023―Mar―02 Abstract P6-05-19: Racial Disparities in the Quality of Life and Vaccination of Breast Cancer Survivors during COVID-19: A Longitudinal Study Fangyuan Zhao, Brenda L. Copley, Sondra H. Birch, Rita Nanda, Olufunmilayo I. Olopade, Dezheng Huo
35 [GO] 2023―Mar―02 Abstract P3-03-04: Cyclin-dependent kinase 4/6 inhibitor in advanced breast cancer during the COVID pandemic period: efficacy in relation to vaccination for SARS-COV 19 Filippo Giovanardi, Edoardo Carretto, Giancarlo Bisagni, Claudia Degli Esposti, Elisa Gasparini, Alessandra Bologna, et al. (+3)
36 [GO] 2023―Mar―02 Abstract P1-06-06: Access to medical coverage in newly diagnosed Breast cancer patients a minority population during the COVID 19 pandemic Tamarah Aldawoodi, Gabriel Roman Souza, Juzar Hussain, Lauren C. Jameson, Lauren Rahman, Nomso C. Agim, et al. (+2)
37 [GO] 2023―Mar―02 Abstract P6-05-45: Providing Educational Resources during the Pandemic for Advanced Breast Cancer Patients Ginny T. Kirklin, Abbey Kaler, Debu Tripathy
38 [GO] 2023―Mar―02 Abstract P3-03-01: The impact of the COVID19 pandemic on treatment practices for patients diagnosed with early breast cancer: a cross-sectional study from a large comprehensive cancer centre in Italy Fabio Girardi, Sabrina Marini, Francesca Porra, Ilaria Mietto, Sonia Carpentieri, Alberto Marchet, et al. (+11)
39 [GO] 2023―Mar―02 Abstract P6-05-51: Best Quality of Care from a Distance (BQual-D): Maintaining high quality care for hormone receptor positive (HR+) metastatic breast cancer (MBC) during the COVID pandemic, patient participation and satisfaction with the program Gretchen Kimmick, Smrithi Divakaran, Heather Moore, Cynthia Rose, Pamela Gentry, Michael Willis, et al. (+6)
40 [GO] 2023―Mar―02 Abstract P6-08-13: Home-based treatment with subcutaneous (SC) trastuzumab - only a pandemic solution? Real world evidence (RWE) analysis Barbara Radecka, Hudała-Klecha Joanna, Dariusz Sawka, Jolanta Sarga, Bożena Noworolska, Jolanta Sawicka, et al. (+3)
41 [GO] 2023―Mar―02 Abstract P4-05-03: Investigating Financial Toxicity among Breast Cancer Patients Diagnosed during the Pandemic: The Role of Cancer Care Disruptions and Social Isolation Chiara Acquati, Tzuan Chen, Isabel Martinez Leal, Shahnjayla Connors, Anastasia Rogova, Mathew Banegas, et al. (+3)
42 [GO] 2022―Dec―02 Abstract A019: Impact of COVID-19 on patient navigation services for follow-up colonoscopy after abnormal fecal testing in community health centers Jamie H. Thompson, Jennifer Rivelli, Jennifer Schneider, Amanda F. Petrik, Gloria D. Coronado
43 [GO] 2022―Nov―15 Abstract A048: Impact of COVID-19 on pancreatic cancer outcomes in Florida Guettchina Telisnor, Alexander S. Lim, Zhongyue Zhang, XiangYang Lou, Ibrahim Nassour, Bo Han, et al. (+2)
44 [GO] 2022―Jun―15 Abstract 435: COVID-19 & cancer prevention in Texas: Reasons cited for HPV vaccination hesitancy and refusal during the pandemic Onyema Chido-Amajuoyi, Mala Pande, Robert Yu, Sanjay Shete
45 [GO] 2022―Jun―15 Abstract 5276: COVID-19 and breast cancer care in Ireland: A qualitative study to explore the perspective of breast cancer patients on their health and health care Charlotte L. Myers, Catherine Waldron, Kathleen Bennett, Caitriona Cahir
46 [GO] 2022―Jun―15 Abstract 3585: Disparities in cancer treatment delays or discontinuation among cancer patients diagnosed with SARS-CoV-2 infection: An analysis of the U.S. ASCO COVID-19 and cancer registry Jessica Yasmine Islam, Cassandra A. Hathaway, Emma Hume, Kea Turner, Julie Hallanger-Johnson, Shelley S. Tworoger, Marlene Camacho-Rivera
47 [GO] 2022―Jun―15 Abstract 2266: Host genetic susceptibility to COVID-19 and pandemic -associated stressors Maria Gonzalez-Pons, Valeria Valentin, Ingrid Montes-Rodriguez, Maria J. Sanchez, Fabiola M. Morales, Ibis R. Vera-Urbina, et al. (+8)
48 [GO] 2022―Jun―15 Abstract 442: Exploring the impact that COVID-19 had on patient distress in a rural cancer center Sierra Silverwood, Kelly Hirko
49 [GO] 2022―Jun―15 Abstract 444: COVID-IRIS: Immune reconstitution after G-CSF administration for neutropenia during acute COVID-19 infection Chloe S. Lalonde, Tony Z. Zhuang, Amalia A. Aldredge, Max W. Adelman, Abeer N. AbouYabis, Morgan L. McLemore, Sara C. Auld
50 [GO] 2022―Jun―15 Abstract 5275: The short-term impact of COVID-19 on lung cancer screening participation and adherence Yannan Lin, William Hsu, Denise R. Aberle, Ashley E. Prosper
51 [GO] 2022―Jun―15 Abstract 441: The impact of the COVID-19 on the screening of breast and cervical cancer in Korea Hyeree Park, Seung Hee Seo, Jong Heon Park, Bhumsuk Keam, Shin Hye Yoo, Aesun Shin
52 [GO] 2022―Jun―15 Abstract 433: Colorectal and gastric cancer screening rates in Korea during the COVID-19 pandemic Seung Hee Seo, Hyeree Park, Jong Heon Park, Bhumsuk Keam, Shin Hye Yoo, Aesun Shin
53 [GO] 2022―Jun―15 Abstract 434: Development of virtual outreach strategies to supply cancer education and prevention information during the COVID-19 pandemic Monica Yellowhair, Desiree Jones, Gabriela Ruiz, Octavio Castanos, Rene D. Herrera, Juan Contreras, et al. (+2)
54 [GO] 2022―Jun―15 Abstract 439: Physical activity among male cancer survivors during the COVID-19 pandemic Colleen B. McGrath, Alaina H. Shreves, Konrad Stopsack, Lilian Cheung, Ann Fisher, Sarah Markt, Lorelei A. Mucci
55 [GO] 2022―Jun―15 Abstract 438: Psychosocial outcomes, sleep, and substance use among male cancer survivors during the COVID-19 pandemic Colleen B. McGrath, Alaina H. Shreves, Konrad Stopsack, Lilian Cheung, Ann Fisher, Sarah Markt, et al. (+2)
56 [GO] 2022―Jun―15 Abstract 440: Diet and supplement use changes among male cancer survivors during the COVID-19 pandemic Alaina H. Shreves, Colleen B. McGrath, Konrad Stopsack, Lilian Cheung, Ann Fisher, Edward Giovannucci, et al. (+3)
57 [GO] 2022―Jun―15 Abstract 2244: Video-based germline testing for individuals with pancreatic ductal adenocarcinoma: Influence of COVID-19 pandemic Saumya Kasliwal, Seyda Baydogan, Devon Harrison, Mark Hurd, Maureen Mork, Anirban Maitra, Florencia McAllister
58 [GO] 2022―Jun―15 Abstract 6231: Predictors of objectively-measured sedentary time during the COVID-19 pandemic among breast cancer survivors participating in a diet and physical activity intervention Sidney Donzella, Chongzhi Di, Eileen Rillamas-Sun, Hanjie Shen, Sofia Cobos, Yuhan Huang, et al. (+4)
59 [GO] 2022―Jun―15 Abstract 6178: COVID-19 pandemic and clinicopathologic characteristics of colorectal cancer in Korea: A multicenter, retrospective study Yoon Dae Han, Jun Sang Shin, Sung Uk Bae, Woo Ram Kim, Dae Ro Lim, Chang Woo Kim
60 [GO] 2022―Jun―15 Abstract 1999: The impact of the COVID-19 pandemic on 30-day survival in pediatric cancer patients in low, middle, and high-income countries: an international, observational cohort study Muhammed Elhadi, Soham Bandyopadhyay, Noel Peter, Kokila Lakhoo
61 [GO] 2022―Jun―15 Abstract 5274: Mechanisms of action (MOA) for proxalutamide, an androgen receptor (AR) antagonist, for the treatment of mild, moderate and severe COVID-19 patients Liandong Ma, Youzhi Tong, Qianxiang Zhou, Hongha Yan, Xiaodan Hou, Zhiha Ren, et al. (+6)
62 [GO] 2022―Jun―15 Abstract 3587: Racial disparity in COVID-19 severity after adjusting for chronic illnesses and sociodemographic factors Xiao-Cheng Wu, Yong Yi, Lauren S. Maniscalco, Mei-Chin Hsieh, DeAnn Gruber, Lee Mendoza, et al. (+3)
63 [GO] 2022―Jun―15 Abstract 3586: Immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CART cell therapy Thierry Iraguha, Saurabh Dahiya, Stephanie Avila, Aaron Rapoport, Tim Luetkens, Djordje Atanackovic
64 [GO] 2022―Jun―15 Abstract 3584: COVID-19 vaccination primary and secondary hesitancy among veterans with cancer in the Arkansas-Louisiana-Texas Region Philip A. Haddad, Dalia Hammoud, Miriam L. Mcgowen, Laura Houston, Monica Craig, Trenesia McCain, et al. (+3)
65 [GO] 2022―Jun―15 Abstract CT258: Interim safety and immunogenicity results of a phase I trial evaluating the multi-peptide COVID-19 vaccine candidate CoVac-1 for induction of SARS-CoV-2 T cell immunity in cancer patients with disease- or treatment-related immunoglobulin deficiency Claudia Tandler, Jonas S. Heitmann, Maddalena Marconato, Yacine Maringer, Monika Denk, Marion Richter, et al. (+6)
66 [GO] 2022―Jun―15 Abstract CT567: Comprehensive measures of COVID-19 vaccine efficacy in adolescent cancer patients: Results from SerOzNET Eva Segelov, Amy Body, Stuart Turville, Corey Smith, Katie Lineburg, Sudha Rao, et al. (+14)
67 [GO] 2022―Jun―15 Abstract 5279: Prognostic serum biomarkers in cancer patients with COVID-19: A systematic review Yun-Ju Lai, Te-An Lee, Shih-Han Wang, Chia-Wei Li, Louise D. McCullough, Dhimiter Bello
68 [GO] 2022―Jun―15 Abstract 5273: The peripheral proinflammatory responses in COVID-19: Clinical spectrum and outcome in patients with and without cancer Amer N. Radwi, Zahra H. Alshardi, Rakan H. Alelyani, Raha M. Garout, Lojain N. Alruwaili, Muhammad T. Bakhsh
69 [GO] 2022―Jun―15 Abstract 446: Outcome of cancer patients with COVID-19: the VCU experience Patrick J. Willard, Temmy Olasehinde, Naji Bou Zeid, Edem Defor, Victor Yazbeck, Dipankar Bandyopadhyay
70 [GO] 2022―Jun―15 Abstract 2056: PI3Kgamma inhibition reduces inflammation and promotes survival in cancer and SARS-CoV-2 Judith A. Varner, Anghesom Ghebremedhin
71 [GO] 2022―Jun―15 Abstract LB226: Requirement for booster doses in healthy, cancer and immunosuppressed patients infected with the ancestral or variant SARS-CoV-2 Chrysovalantis Voutouri, C. Corey Hardin, Vivek Naranbhai, Melin J. Khandekar, Justin F Gainor, Triantafyllos Stylianopoulos, et al. (+2)
72 [GO] 2022―Jun―15 Abstract 2937: Mutational analysis of ORF-8 of SARS-CoV-2 - a window to immunotherapy Gopika Trieu, Nikita Mehta, Jeffrey Park, Andrew Ionescu, Lily Asgari, Vuong Trieu
73 [GO] 2022―Jun―15 Abstract 5272: Aberrant DNA 5mC and 6mA methylations increase ACE2 expression in intestinal cancer cells susceptible to SARS-CoV-2 infection Heng Wang, Yumo Xie, Gaopo Xu, Xiaolin Wang, Meijin Huang, Yanxin Luo, Huichuan Yu
74 [GO] 2022―Jun―15 Abstract 4249: Quantitative PBMC ADCC bioassay and ADCC reporter bioassays for immunotherapy and SARS-CoV-2 monoclonal antibody development Pete Stecha, Jun Wang, Denise Garvin, Julia Gilden, Jamison Grailer, Jim Hartnett, et al. (+3)
75 [GO] 2022―Jun―15 Abstract 437: Characterization of SARS-CoV-2 using the Ion AmpliSeq SARS-CoV-2 research panel Desiree Unselt, Katherine Knudsen, Christopher Rounds, Janet Doolittle-Hall, Fernando Torres, Jennifer Sims, Jennifer Mason
76 [GO] 2022―Jun―15 Abstract 5277: Humoral SARS-CoV-2 response in asymptomatic precursor plasma cell dyscrasia patients: IMPACT study results Yoshinobu Konishi, Romanos Sklavenitis-Pistofidis, Hong Yue, Federico Ferrari, Massimiliano Russo, Robert A. Redd, et al. (+13)
77 [GO] 2022―Jun―15 Abstract CT259: Comprehensive humoral and cellular immune assessments to SARS-CoV-2 (wild type, delta and omicron) following two- and three-dose vaccination schedule in a large adult cancer population: SerOzNET study: placeholder abstract Eva Segelov, Amy Body, Vi Luong, Veronica Aedo Lopez, Luxi Lal, Hesham Abdulla, et al. (+9)
78 [GO] 2022―Jun―15 Abstract 436: Rapid flow cytometric whole blood assay for assessment of SARS-CoV-2-reactive T cell immunity Lorenz Fülle, Philipp David Gert, Verena Traska, Sofia Chatzopoulou, Christian Dose, Anne Richter, Marc Schuster
79 [GO] 2022―Jun―15 Abstract 3582: Single-cell RNA-sequencing for immune profiling of SARS-CoV2 vaccine response in healthy individuals and patients with precursor plasma cell malignancies Romanos Sklavenitis-Pistofidis, Yoshinobu Konishi, Michelle Aranha, Mahshid Rahmat, Ting Wu, Michael Timonian, et al. (+13)
80 [GO] 2022―Mar―08 Abstract P4-12-09: Implications of protocol modifications and treatment delays for breast cancer patient experiences during Covid-19 Tamara Hamlish, Elizabeth L Papautsky
81 [GO] 2022―Mar―08 Abstract P3-01-12: The impact of COVID-19 on diagnosis of recurrent breast cancer Serena Di Cosimo, Catherine Depretto, Rosalba Miceli, Paolo Baili, Silva Ljevar, Milena Sant, et al. (+12)
82 [GO] 2022―Mar―08 Abstract P2-11-08: Impact of COVID-19 on patients undergoing neoadjuvant therapy: A pre/post pandemic analysis and assessment of quality of care delivered Lauren Corke, Omar Hajjaj, Kaylie Willemsma, Stephen Chia, Christine Simmons
83 [GO] 2022―Mar―08 Abstract P2-10-05: The estimated impact of COVID-19 on population breast cancer screening outcomes, and options for risk-based recovery Pietro Procopio, Sabine Deij, Louiza S Velentzis, Amanda Tattam, Lara Petelin, Carolyn Nickson
84 [GO] 2022―Mar―08 Abstract P1-17-07: Consequences of stopping a 4/6 cyclin D-dependent kinase Inhibitor in metastatic breast cancer patients with clinical benefit on endocrine treatment, in the context of the COVID-19 outbreak Sophie Martin, Carole Pflumio, Philippe Trensz, Frederique Schaff-Wendling, Michal Kalish, Cathie Fischbach, et al. (+4)
85 [GO] 2022―Mar―08 Abstract P3-12-37: The impact of the COVID-19 outbreak on breast cancer stage in the Netherlands by screening status Anouk H Eijkelboom, Sabine Siesling, Linda de Munck, Carla H van Gils, Marc BI Lobbes, Vivianne CG Tjan-Heijnen, et al. (+4)
86 [GO] 2022―Mar―08 Abstract P3-12-09: Impact of the COVID-19 outbreak on the treatment strategy of Dutch breast cancer patients Anouk H Eijkelboom, Sabine Siesling, Linda de Munck, Desiree HJG van den Bongard, Willemien Menke-van der Houven van Oordt, Pieter J Westenend, et al. (+12)
87 [GO] 2022―Mar―08 Abstract P5-14-06: Predictors of adherence to oral endocrine therapy in racial and ethnic minority patients with low socioeconomic status before and during the COVID-19 pandemic Sama Rahimi, Onyebuchi Ononogbu, Anjana Mohan, Daniel Moussa, Susan Abughosh, Meghana V Trivedi
88 [GO] 2022―Mar―08 Abstract P5-14-03: National claims data analysis of breast cancer diagnosis and treatment before versus during the COVID-19 pandemic Jennifer L Caswell-Jin, Maryam N Shafaee, Lan Xiao, Mina Liu, Natasha Purington, Esther M John, et al. (+2)
89 [GO] 2022―Mar―08 Abstract P5-14-15: Examining inequities related to inpatient hospital length of stay for breast cancer patients: A retrospective study during the COVID-19 pandemic Sailaja Kamaraju, Bethany Canales, Tamiah Wright, John Charlson, Aniko Szabo, Thomas Wetzel, et al. (+2)
90 [GO] 2022―Mar―08 Abstract P5-14-01: National claims data analysis of breast cancer diagnosis and treatment before versus during the COVID-19 pandemic Jennifer L Caswell-Jin, Maryam N Shafaee, Lan Xiao, Mina Liu, Natasha Purington, Esther M John, et al. (+2)
91 [GO] 2022―Mar―08 Abstract P2-13-17: A phase III, randomized, multicenter, double-blind study to compare efficacy and safety of EG12014 (EirGenix trastuzumab) with Herceptin® as neoadjuvant treatment in combination with anthracycline/paclitaxel-based systemic therapy in patients with HER2-positive early breast cancer - a multinational phase III study conducted during the COVID-19 pandemic Barbara Grohmann-Izay, Chiun-Sheng Huang, Giorgi Dzagnidze, Nestor Llinas, Anand Misra, Denys Pominchuk, et al. (+6)
92 [GO] 2022―Mar―08 Abstract P3-04-04: Multi-institutional perspective on screening mammography and breast cancer stage at diagnosis during the COVID-19 pandemic Sarah J Stephens, Maxwell R Lloyd, Julian C Hong, Tejas Mehta, Ted A James, Rachel Blitzblau, et al. (+2)
93 [GO] 2022―Mar―08 Abstract P3-23-04: A comprehensive, multidisciplinary approach to breast cancer treatment during the COVID-19 pandemic improves time to treatment Amila Orucevic, Robin Hutson, Robert Heidel, Jillian Lloyd, Garnetta Morin-Ducote, Christine Lauro, et al. (+5)
94 [GO] 2022―Mar―08 Abstract P4-12-12: Assessing the impact of the COVID-19 pandemic on cancer treatment decision-making and care experiences Noura Alsafar, Desiree Hao, Nimira Alimohamed, Sunil Samnani, Sasha Lupichuk
95 [GO] 2022―Mar―08 Abstract P3-09-19: The utility of using genomic testing on needle core biopsies during the COVID-19 pandemic: Molecular characterization, risk stratification, neoadjuvant outcome, and future implications Hani Katerji, Huina Zhang, Xi Wang, Linda Schiffhauer, Ajay Dhakal, Alissa Huston, et al. (+3)
96 [GO] 2022―Mar―08 Abstract P3-03-19: Incidence and time to resolution of axillary adenopathy on mammography after COVID-19 vaccination Kristin Robinson, Santo Maimone, Pooja P Advani, Zhuo Li, Denise Gococo-Benore, Neda Qosja, et al. (+8)
97 [GO] 2022―Mar―08 Abstract P1-01-01: Prospective ultrasonographic surveillance study for incidence and recovery period of COVID-19 vaccination-related axillary lymphadenopathy Kumiko Kida, Hiroko Tsunoda, Risa Kasahara, Chika Tsutsumi, Akiko Numata, Yuri Takehara, et al. (+5)
98 [GO] 2022―Mar―08 Abstract P5-14-17: Declining the COVID-19 vaccination: An evaluation of why some high risk cancer patients decline vaccination Kate I Lathrop, Eva Prieto, Stefany Viveros, Salyna Riggs, Eva Balboa, Juanita Murray, et al. (+2)
99 [GO] 2022―Mar―08 Abstract P2-15-03: Neoadjuvant endocrine therapy (NET) as bridge therapy for early stage breast cancer during COVID-19: A single institution experience Julie Huang, Joshua Feinberg, Bahram Dabiri, Jordan Baum, Meredith Akerman, Anthony Pasquarella, et al. (+4)
100 [GO] 2022―Mar―08 Abstract P2-03-01: Changes in breast cancer presentation during Covid-19: Experience in an Urban Academic Center Amber Azniv Guth, Brian Diskin, Freya Schnabel, Nakisa Pourkey, Deborah Axelrod, Richard Shapiro
101 [GO] 2022―Mar―08 Abstract P5-14-20: Neoadjuvant endocrine therapy (NET) during COVID-19: Single institution survey of patients’ perspectives Julie Huang, Joshua Feinberg, Meredith Akerman, Anthony Pasquarella, Abhinav Rohatgi, Bahram Dabiri, et al. (+4)
102 [GO] 2022―Mar―08 Abstract P3-23-01: Antibody responses after SARS-CoV-2 mRNA vaccination in breast cancer patients Saranya Chumsri, Pooja P. Advani, Tanmayi S Pai, Zhou Li, Marites Acampora, Gina A Reynolds, et al. (+3)
103 [GO] 2022―Mar―08 Abstract P4-10-03: Immunogenicity of SARS-CoV-2 vaccination in subjects on active treatment for breast cancer Cory Bivona, Kevin Li, Priyanka Sharma, Jianghua He, Grace Martin, Andrew K Godwin, et al. (+19)
104 [GO] 2022―Mar―08 Abstract P3-23-02: Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer receiving CDK 4/6 inhibitors Elyssa Denault, Erika Nakajima, Vivek Naranbhai, Alejandro Balazs, Lindsey Mortensen, Elizabeth Niehoff, et al. (+11)
105 [GO] 2022―Mar―08 Abstract P3-11-02: Evaluation of the effects of anticancer treatments in cancer patients undergoing SARS-COV2 vaccination (VAX-on study: Breast cancer subgroup analysis) Agnese Fabbri, Eleonora Marrucci, Fabrizio Nelli, Marco Mazzotta, Angelo Onorato, Primi Francesca, et al. (+7)
106 [GO] 2022―Mar―08 Abstract P4-10-06: Best quality care from a distance (BQual-D): Maintaining high quality care for hormone receptor positive (HR+) metastatic breast cancer (MBC) during the COVID pandemic, description of the program and provider satisfaction Gretchen Kimmick, Smrithi Davakaran, Heather Moore, Cynthia Rose, Pamela Gentry, Michael Willis, et al. (+6)
107 [GO] 2022―Mar―08 Abstract P4-12-13: Psychosocial aspects in relation to clinical status of breast cancer patients after prolonged COVID pandemic in south India: A observational survey study Chandralekha Krishnan
108 [GO] 2022―Mar―08 Abstract P5-14-04: Changes in management of TNBC during the COVID19 pandemic of 2020 Dave Smart, Wendy L Allen, Raymond H Henderson, Susanne Munksted, Peter Riccelli
109 [GO] 2022―Mar―08 Abstract P3-17-06: Telephone triaging during the 1st wave of the COVID 19 Pandemic: Outcomes and proposed pathway for managing patients referred for breast pain Urvashi Jain, Robyn Coombe, Georgina Bitsakou, Ashutosh Kothari
110 [GO] 2021―Nov―10 Longitudinal SARS-CoV-2 mRNA vaccine-induced humoral immune responses in cancer patients Jane C Figueiredo, Noah M Merin, Omid Hamid, So Yung Choi, Tucker Lemos, Wendy Cozen, et al. (+27)
111 [GO] 2021―Jul―01 Abstract 703: An inflammatory leptomeningeal signature in cancer patients with neurologic manifestations of COVID-19 Jessica A. Wilcox, Jan Remsik, N. Esther Babady, Tracy A. McMillen, Behroze A. Vachha, Neil A. Halpern, et al. (+6)
112 [GO] 2021―Jul―01 Abstract 710: Androgen-deprivation therapy boosts MX1 expression, a silent effector against COVID-19 Juan Antonio Bizzotto, Pablo Sanchis, Sofia Lage-Vickers, Rosario Lavignolle, Agustina Sabater, Mercedes Abbate, et al. (+9)
113 [GO] 2021―Jul―01 Abstract 714: From cancer to COVID-19- development of a dendritic cell-targeted nano-vaccine for prevention and therapy of COVID-19 Daniella Vaskovich-Koubi, Ron Kleiner, Yulia Liubomirski, Eilam Yeini, Galia Tiram, Sabina Pozzi, et al. (+3)
114 [GO] 2021―Jul―01 Abstract 704: Sex and age differences in telomere length and susceptibility to COVID-19 Manar Ahmed Kamal, Kareem Reda Alamiry, Mahmoud Zaki
115 [GO] 2021―Jul―01 Abstract 711: Repurposing 2nd generation androgen receptor antagonist Proxalutamide to treat COVID-19 Liandong Ma, Youzhi Tong, Qiang Guo, Yifeng Zhou, Qianxiang Zhou, Honghua Yan
116 [GO] 2021―Jul―01 Abstract 709: Estrogen and androgen receptor inhibitors: Unexpected allies in the fight against COVID-19 Sara Bravaccini, Eugenio Fonzi, Michela Tebaldi, Davide Angeli, Giovanni Martinelli, Fabio Nicolini, et al. (+2)
117 [GO] 2021―Jul―01 Abstract 700: CellSig: A data-driven model of cytokine activity identifies therapeutic targets for severe COVID-19 and cancer immunotherapy-induced colitis Peng Jiang, Yu Zhang, Beibei Ru, Eytan Ruppin, Kai Wucherpfennig
118 [GO] 2021―Jul―01 Abstract 722: The hallmark of COVID-19 cancer disparities: Cellular sequelae Eva McGhee, Mengtao LI, Yi-Ling Lin, Nefertari Carr, Chinelo Njubigbo, Rohun Sadeghi, et al. (+6)
119 [GO] 2021―Jul―01 Abstract LB076: Association between regional COVID-19 hospitalizations and treatment delays amongst confirmed cancer patients in England, UK Louis Fox, Ajay Aggarwal, Richard Sullivan, Kate Haire, Arnie Purushotham, James Spicer, et al. (+4)
120 [GO] 2021―Jul―01 Abstract LB074: Chymostatin, a cathepsin L inhibitor, inhibits lung cancer cell proliferation and COVID-19 Mpro in vitro Nagendra Sastry Yarla, Gopal Pathuri, Simon Terzyan, Yuting Zhang, Anil Singh, Marcus T. Scotti, et al. (+2)
121 [GO] 2021―Jul―01 Abstract CT201: Early report of a phase I/II study of human placental hematopoietic stem cell derived natural killer cells (CYNK-001) for the treatment of adults with COVID-19 (NCT04365101) Corey Casper, Leonid Groysman, Vinay Malhotra, Eric Whitman, Stacy Herb, Erica Rave, et al. (+17)
122 [GO] 2021―Jul―01 Abstract LB073: The growth inhibitory effect of paclitaxel on gefitinib-resistant non-small cell lung cancer (NSCLC) cells during the COVID-19 pandemic Md Mohiuddin, Hideharu Kimura, Takashi Sone, Satoshi Watanabe, Hiroki Matsuoka, Keigo Saeki, et al. (+3)
123 [GO] 2021―Jul―01 Abstract 716: Telehealth use among multiple myeloma patients during the COVID-19 pandemic Nathan W. Sweeney, Scott R. Goldsmith, Jennifer M. Ahlstrom
124 [GO] 2021―Jul―01 Abstract 719: The emergence of the COVID-19 pandemic and its impact on a novel cancer care delivery model at Federally Qualified Health Centers Nicolas Francone, Will Dunne, Jonathan Alhalel, Sankirtana Danner, Nihmotallahi Adebayo, T Madorsky, et al. (+6)
125 [GO] 2021―Jul―01 Abstract 717: Rapid transformation of TTFields care-delivery during COVID-19 pandemic to optimize treatment of patients with glioblastoma (GBM) Peggy M. Frongillo, Melissa Shackelford, Lindsay Rain
126 [GO] 2021―Jul―01 Abstract 721: Early death in acute lymphoblastic leukemia during COVID-19 pandemic: A single institution cohort study Daniel J. Enriquez-Vera, Ali Al-kassab-Cordova, Lizbeth Lachira-Yparraguirre, Gustavo Sandival-Ampuero, Bryan Valcarcel, Cesar Samanez, et al. (+5)
127 [GO] 2021―Jul―01 Abstract 1162: Monitoring COVID-19 RNA methyltransferases activities for developing therapeutic drugs Said A. Goueli, Kevin Hsiao
128 [GO] 2021―Jul―01 Abstract 715: Flow cytometry analysis of immune response to COVID-19 vaccine candidates using an in vitro stimulation model Xiaoshan Shi, Scott J. Bornheimer, Suraj Saksena, Stephanie Widmann, Aaron Tyznik
129 [GO] 2021―Jul―01 Abstract 712: Anticancer natural compounds as potential inhibitors of novel coronavirus (COVID19) main protease: An in-silico study Amaresh Mishra, Yamini Pathak, Gourav Choudhir, Anuj Kumar, Surabhi Kirti Mishra, Vishwas Tripathi
130 [GO] 2021―Jul―01 Abstract 706: Rapid detection of SARS-CoV-2 antigen and antibody seroconversion in clinical specimens using a novel Surface Programmable Activation Receptor (SPAR) modified T cell diagnostic method Aaron K. LeFebvre, Melissa Frenchmeyer, Kyle M. McQuaid, MRussell Williams, Charles M. McBrairty, Joseph D. Kittle
131 [GO] 2021―Jul―01 Abstract 713: Inhibition of pseudo SARS-CoV-2 binding activity of a anti-cancer polypharmacological agent analogs Rao V. Papineni, Amitava Adhikary, Ritesh Tandon, Dipanwita Mitra
132 [GO] 2021―Jul―01 Abstract 707: Detection of SARS-CoV-2 co-infections with seasonal respiratory viruses using a multiplexed amplicon NGS panel Lucie S. Lee, Rounak Feigelman, David Debruyne, Julia Spencer, Chenyu Li, Zhitong Liu, Guoying Liu
133 [GO] 2021―Jul―01 Abstract 701: The acute phase response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection as quantified by the OnCovid Inflammatory Score Gino M. Dettorre, Saoirse Dolly, Angela Loizidou, John Chester, Amanda Jackson, Uma Mukherjee, et al. (+44)
134 [GO] 2021―Jul―01 Abstract 705: SARS-CoV-2 infection of the human heart governs intracardiac innate immune response Anthony W. Ashton, Liang Zhang, Yan Liang, Prajan Divakar, Carolos Cordon-Cardo, Richard G. Pestell
135 [GO] 2021―Jul―01 Abstract LB075: Development of SARS-CoV-2 neutralizing protein by ACE2 receptor engineering for severe infection and patients with underlying diseases Byoung S. Kwon, Seunghyun Lee, Jin-Kyung Choi, Bora Hwang, Sun-Woo Im, Yun-Sook Lim, et al. (+3)
136 [GO] 2021―Jul―01 Abstract LB072: SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus Zhiqiang Qin, Jungang Chen, Lu Dai, Lindsey Barrett, Steven Post
137 [GO] 2021―Jul―01 Abstract 702: Single-cell expression landscape of SARS-CoV-2 receptor ACE2 and host proteases in human lung adenocarcinoma Guangchun Han, Ansam Sinjab, Kieko Hara, Warapen Treekitkarnmongkol, Patrick Brennan, Kyle Chang, et al. (+25)
138 [GO] 2021―Feb―15 Abstract PS7-01: Characteristics and outcomes of SARS-CoV-2 infection in patients with invasive breast cancer (BC) from the COVID-19 and cancer consortium (CCC19) cohort study Ali Raza Khaki, Dimpy P Shah, Maryam B Lustberg, Melissa K Accordino, Daniel G Stover, Gayathri Nagaraj, et al. (+15)
139 [GO] 2021―Feb―15 Abstract PS12-26: “Bridge” neoadjuvant endocrine therapy for early stage breast cancer patients during COVID-19 at an academic hospital in NYC: Lessons learned Cindy Cen, Freya Schnabel, Sylvia Adams, Magdalena Plasilova, Janet Yeh, Marleen Meyers, et al. (+6)
140 [GO] 2021―Feb―15 Abstract PS8-26: The new normal; adjusting to remote ways of providing bespoke weight management support to breast cancer survivors during the COVID-19 global pandemic Katie Pickering, Sarah Wane, Helen Speake, Helen Crank, Annie Anderson, Henry Cain, et al. (+9)
141 [GO] 2021―Feb―15 Abstract SS2-03: Patterns of medical behavior in the management of breast cancer during COVID-19. Mexican Experienc Ricardo Villalobos Valencia, Samuel Rivera Rivera
142 [GO] 2021―Feb―15 Abstract PS6-32: Impact of COVID-19 on breast cancer care at a Bay Area academic center Julie Wu, Sally Bobo, Solomon Henry, Meredith Mills, Allison Kurian, Frederick Dirbas
143 [GO] 2021―Feb―15 Abstract SS2-10: Impact of COVID-19 on study sites: Survey analysis from the noninterventional POLARIS study Debu Tripathy, Joanne L Blum, Gabrielle Rocque, J. Daniel Cuevas, Jennifer Specht, Steven Corso, et al. (+5)
144 [GO] 2021―Feb―15 Abstract SS2-04: Health maintenance and breast cancer screening during the COVID-19 pandemic Arash Naeim, Neil Wenger, Karen Sepucha, Annette Stanton, Ryan Baxter-King, Leah Sabacan, et al. (+5)
145 [GO] 2021―Feb―15 Abstract SS2-09: Telemedicine usability for cancer care during the COVID-19 pandemic Andrea Leon, Rebecca Kaltman, Hannah Arem, Richard Amdur, Andrea Gesteira, Samuel Duffy, et al. (+3)
146 [GO] 2021―Feb―15 Abstract PS2-27: Benefits of a rapid diagnostic centre for breast cancer care during the COVID-19 pandemic Gary Ko, Sharmy Sarvanantham, Sangita Sequeira, Vrutika Prajapati, David R. McCready, Vivianne Freitas, Tulin D. Cil
147 [GO] 2021―Feb―15 Abstract PS13-30: Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic Franklin F Pimentel, Jessica MC Borba, Tamara CGF Rodrigues, Karoline PI Peruchi, Helio HA Carrara, Jurandyr M de Andrade, Francisco J Candido dos Reis
148 [GO] 2021―Feb―15 Abstract SS2-02: Patient perception of breast and gynecologic cancer care during the SARS-CoV-2 (COVID-19) pandemic in NYC: A single center survey-based study Brittney S Zimmerman, Danielle Seidman, Natalie Berger, Krystal P Cascetta, Michelle Nezolosky, Kara Trlica, et al. (+4)
149 [GO] 2021―Feb―15 Abstract SS2-08: Patient perception of telehealth services for breast and gynecologic cancer care during the SARS-CoV-2 (COVID-19) pandemic in NYC: A single center survey-based study Brittney S Zimmerman, Danielle Seidman, Natalie Berger, Krystal P Cascetta, Michelle Nezolosky, Kara Trlica, et al. (+4)
150 [GO] 2021―Feb―15 Abstract PS11-21: First-line treatment trends in metastatic breast cancer before and at the early stage of the COVID-19 pandemic in the United States Samantha Kurosky, Xianchen Liu, Aster Meche, Rebecca Levin, Amy Sullivan, Lynn McRoy
151 [GO] 2021―Feb―15 Abstract PS7-88: Effect of the COVID-19 pandemic on the initial treatment of breast cancer in the Netherlands: A population-based study Anouk H Eijkelboom, Linda de Munck, Marie-Jeanne Vrancken Peeters, Marjolein Smidt, Mireille Broeders, Monique Bos, et al. (+14)
152 [GO] 2021―Feb―15 Abstract SS2-01: Impact of the COVID-19 pandemic on the multidisciplinary management of breast cancer: Initial analysis of the american society of breast surgeons mastery COVID-19 registry Lee Gravatt Wilke, Toan T Nguyen, Qiuyu Yang, Bret M Hanlon, Kathryn A Wagner, Pamela Strickland, et al. (+3)
153 [GO] 2021―Feb―15 Abstract SS2-07: Predictors for fear of cancer recurrence in breast cancer patients referred for radiation therapy during the COVID-19 pandemic: A multi-center cross-section survey Jinrong Xie, Weixiang Qi, Lu Cao, Yuting Tan, Jin Huang, Xiaodong Gu, et al. (+20)
154 [GO] 2021―Feb―15 Abstract SS2-05: Emerging from COVID-19 pandemic: Provider perspective on use of neoadjuvant endocrine therapy (NET) in early stage hormone receptor positive breast cancer Ko Un Park, Megan E Gregory, Maryam B Lustberg, Jose G Bazan, Chengli Shen, Shoshana M Rosenberg, et al. (+5)
155 [GO] 2021―Feb―15 Abstract PS6-47: Breast cancer and COVID-19: Impact of active treatment on severe outcomes Karine Tawagi, Jeff Burton, Michael Lunski, Diana Maslov, John Cole
156 [GO] 2021―Feb―15 Abstract PS2-32: Incidental malignant findings on pre-admission chest computed tomography scan for coronavirus disease screening in patients with breast cancer or other cancers Jun Masuda, Akemi Kataoka, Katsunori Oikado, Natsue Uehiro, Yukinori Ozaki, Lina Inagaki, et al. (+5)
157 [GO] 2021―Feb―15 Abstract SS2-06: Characterization of breast cancer management during the COVID 19 pandemic in a large integrated healthcare delivery system: Stage at diagnosis and timing/modality of first treatment Sharon B. Chang, Alison C. Savitz, Brooke Vuong, Annie Tang, Margaret Mentakis, Amy M. Miller, et al. (+2)
158 [GO] 2020―Dec―22 Is COVID-19 - induced platelet activation a cause of concern for cancer patients? Lenard M. Lichtenberger, K. Vinod Vijayan
159 [GO] 2020―Sep―04 Abstract CT405: Experience in using oncology drugs in patients with COVID-19 Paolo A. Ascierto
160 [GO] 2020―Sep―04 Abstract CT402: TERAVOLT (Thoracic cancERs international coVid 19 cOLlaboraTion): First results of a global collaboration to address the impact of COVID-19 in patients with thoracic malignancies Marina Chiara Garassino
161 [GO] 2020―Sep―04 Abstract CT403: Outcome of cancer patients infected with COVID-19, including toxicity of cancer treatments Fabrice Barlesi, Stéphanie Foulon, Arnauld Bayle, Bertrand Gachot, Fanny Pommeret, Christophe Willekens, et al. (+12)
162 [GO] 2020―Sep―04 Abstract CT406: Patients with cancer appear more vulnerable to SARS-COV-2: A multi-center study during the COVID-19 outbreak Meng-Yuan Dai, Dian-bo Liu, Miao Liu, Fu-Xiang Zhou, Gui-Ling Li, Zhen Chen, et al. (+32)
163 [GO] 2020―Sep―04 Abstract CT401: The experience of treating patients with cancer during the COVID-19 pandemic in China Li Zhang, F Zhu, L Xie, C Wang, J Wang, R Chen, et al. (+12)
 [1] 

163 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.020 sec